David Shaw’s Takeda Pharmaceutical TAK Stock Holding History

David Shaw’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,000	Closed	-$273K	–	4476
2020 Q4	$273K	Hold	15,000	–	–	﹤0.01%	3634
2020 Q3	$268K	Hold	15,000	–	–	﹤0.01%	3496
2020 Q2	$269K	Buy	+15,000	New	+$269K	﹤0.01%	3667
2020 Q1	–	Sell	-136,816	Closed	-$2.7M	–	4245
2019 Q4	$2.7M	Hold	136,816	–	–	﹤0.01%	2229
2019 Q3	$2.35M	Hold	136,816	–	–	﹤0.01%	2234
2019 Q2	$2.42M	Hold	136,816	–	–	﹤0.01%	2111
2019 Q1	$2.79M	Buy	+136,816	New	+$2.75M	﹤0.01%	1936

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

David Shaw's TAK Position: Q2 2026 in Review

David Shaw reduced its Takeda Pharmaceutical (TAK) stake by 21% in Q2 2026, selling an estimated $9.15M and leaving 2,049,467 shares worth $32.9M. The position accounts for 0.02% of the portfolio, ranked #994.

David Shaw first reported a position in TAK in Q1 2019 and has held it in 18 quarters since. The position peaked at $66.9M in Q4 2025. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

David Shaw held 2,049,467 shares of Takeda Pharmaceutical worth $32.9M as of Q2 2026.
David Shaw sold 553,076 Takeda Pharmaceutical shares in Q2 2026, an estimated $9.15M.
Takeda Pharmaceutical made up 0.02% of David Shaw's portfolio in Q2 2026, its #994 holding.
David Shaw first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 18 quarters since.
David Shaw's Takeda Pharmaceutical position peaked at $66.9M in Q4 2025.
375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.